Drug-induced hyperglycemia.
Luna
B
B
Division of Endocrinology, Metabolism and Nutrition, Duke University Medical Center, Box 3921, Durham, NC 27710, USA.
Feinglos
M N
MN
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001581:Benzothiadiazines; D003920:Diabetes Mellitus / Q000139:chemically induced*; D004232:Diuretics; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D011480:Protease Inhibitors / Q000009:adverse effects*; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D014150:Antipsychotic Agents; D001581:Benzothiadiazines; D004232:Diuretics; D011480:Protease Inhibitors; D049993:Sodium Chloride Symporter Inhibitors